Paracetamol

• A Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients with Progressive Multiple Sclerosis Ended
  2023-506429-13-00 Phase III 7 countries F. Hoffmann-La Roche AG
• A Phase 3 Study of NTLA 2001 in participants with amyloidosis with cardiac muscle disease. Halted
  2023-507220-23-00 Phase III 14 countries Intellia Therapeutics Inc.
• The effects of 2-week long treatment with naproxen sodium (Nalgesin® Forte) on synovial fluid cytokine and naproxen concentration and clinic… Ended
  2023-505875-56-00 Phase IV 1 country KRKA tovarna zdravil d.d. Novo mesto
• A Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Once Daily Diclofenac Gel AMZ001 … Ended
  2024-517404-11-00 Phase III 3 countries Amzell B.V.
• Randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of an Esflurbiprofen Topical System (EFTS) vs. … Ended
  2024-513063-45-00 Phase III 1 country Teikoku Seiyaku Co. Ltd.
• Rebound pain after volar plate surgery in infraclavicular brachial plexus block with ropivacaine 3.75 mg/ml compared with 7.5 mg/ml. A prosp… Ended
  2024-514795-41-00 Phase IV 1 country Oslo University Hospital HF
• An open-label, multi-centric trial to assess the safety and efficacy of an Esflurbiprofen Topical System (EFTS) in the local symptomatic and… Ended
  2024-513064-26-00 Phase III 1 country Teikoku Seiyaku Co. Ltd.
• A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Subcutaneous CT-P13 in … Ended
  2024-510945-32-00 Phase III 1 country Celltrion Inc.
• Perioperative oral analgesia versus intravenous analgesia for knee arthroscopy, a randomized, double-blinded, non-inferiority trial. OVIKA-t… Ended
  2024-510789-17-00 Phase IV 1 country UZ Leuven
• Co-administration of Acetaminophen with Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants – The ACEDUCT Trial Ended
  2023-503209-13-00 Phase II 1 country Royal College Of Surgeons In Ireland
• A placebo-controlled, double-blinded, randomized, dose-finding trial using a combination of apocynin and paeonol (APPA) for the treatment of… Ended
  2023-508791-11-00 Phase II 1 country Akl Research & Development Limited
• Efficacy of Intrathecal Morphine for Postoperative Analgesia with or without Suprainguinal Fascia Iliaca Block After Total Hip Arthroplasty:… Ended
  2024-511946-38-00 Phase IV 1 country Centre hospitalier universitaire de Liege
• Dose-response characterization of VER-01 in the treatment of patients with chronic non-specific low back pain Ended
  2023-507358-34-00 Phase II 4 countries Vertanical GmbH
• Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First in-Human, Consecutive-Cohort, Clinical Trial of BI 1910, a Monoclonal Antibody to… Ended
  2022-503066-74-00 Phase I (FiH) 5 countries Bioinvent International AB
• A clinical trial to investigate efficacy and safety of NT 201 injections compared with placebo injections in participants aged 18 years and … Ended
  2022-501461-52-00 Phase II 6 countries Merz Therapeutics GmbH
• Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy (EXPA… Ended
  2023-503830-27-00 Phase II 3 countries Allogene Therapeutics Inc.
• Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma (ALPHA2) Ended
  2022-501927-25-00 Phase II 2 countries Allogene Therapeutics Inc.
• A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus … Ended
  2022-500177-13-00 Phase II 5 countries Gilead Sciences Inc.
• A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polys… Ended
  2022-500228-31-01 Phase II/III 3 countries Paradigm Biopharmaceuticals (USA) Inc.
• Clinical trial on Spinal Anaesthesia vs. General Anaesthesia (SAGA) on recovery after hip and knee replacements Ended
  2022-501221-21-00 Phase IV 1 country Hvidovre Hospital
• A proof-of-concept study to examine QUC398 in participants with knee osteoarthritis Ended
  2023-509274-28-00 Phase II 3 countries Novartis Pharma AG
• A 12-month, randomized, single-blind, placebo-controlled exposure-response study of TCD601 (siplizumab) in new onset type 1 diabetes patient… Ended
  2023-506837-31-00 Phase II 4 countries Itb-Med AB
• Detect GHB Ended
  2022-501329-18-00 Phase III/IV 1 country Aarhus University
• Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Ended
  2022-502773-41-00 Phase I/II 4 countries AstraZeneca AB

Showing 73–96 of 107 trials